Content Syndication Downloads
Content Syndication Downloads are provided as a complimentary service by PentaVision LLC and its magazines. In submitting the registration form you agree to providing express consent to PentaVision LLC to share this contact information with the organization providing white papers that you download from this site.
Lowering of the intraocular pressure (IOP) has been shown to delay or prevent development of glaucomatous damage and its progression. However, as the disease frequently remains asymptomatic until relatively late stages, identification of subjects at high risk for developing glaucoma is important in order to allow early treatment and prevention of irreversible vision loss. Conversely, some patients are unnecessarily treated for high IOP when, in fact, glaucoma is not actually present.
Besides IOP, other factors such as age, central corneal thickness (CCT), disc hemorrhages, and structural and functional measures of the optic nerve have been identified as associated with risk of glaucoma development. In a recently published prospective investigation by Medeiros et al, baseline corneal hysteresis (CH) measurements, collected from a cohort of patients suspected of having the disease, were more predictive of development of glaucomatous visual field defects over time than other risk factors.
The study provides strong evidence that Corneal Hysteresis, over a 5-year period, is a risk factor for glaucoma development, and that for each 1 mmHg lower of Corneal Hysteresis, there was a 21% higher risk of glaucoma development. Read the full article here…
Patients with diabetic retinopathy can present difficult clinical questions, even to the most experienced experts. While measurements like vision loss signify disease progression, visual acuity gains do not necessarily correlate with improvement in structure or global function. Despite the array of diagnostic modalities available to you, very few deliver actionable information that is helpful in deciding if treatment is working, when to change course, or perhaps even when to cease treatment because risks outweigh the potential benefits.
Read more about a fundamental test that can help. Download the ebook today.
Tired of losing time and money on missed appointments? Here's the bottom line: just a few no–shows per week will cost your practice tens (or hundreds) of thousands of dollars every year.
This free eBook spills the secrets used by the most successful practices to:
• Identify and prevent the triggers that lead to patient no–shows
• Communicate more effectively with your patients
• Collect more reliable appointment confirmations
• Increase patient accountability
• Deal with your chronic no–showers
• Avoid and fill last–minute appointment cancellations
You simply can't afford to let the no-show epidemic go untreated, so download your free eBook today.
OPHTHALMOLOGY CASE STUDY: IntelleChartPRO
For approximately 18 months, McKnight Eye Centers, a single-location ophthalmology practice in Liberty, Mo., dealt with the frustrations that came along with a generic EMR solution. "it's more hospital-based EMR," said Erin Grisafe, Practice Administrator of McKnight Eye Centers. "Ophthalmology is just a pea-sized portion of our previous EMR, so if you're not really in a hospital, it had so much stuff that really didn’t pertain to us ... it didn't take long before the doctors really hated it."
EBook: The Numbers Don’t Lie: 16 Facts About Texting That Will Change The Way You Engage Patients EB
Here are 16 Stats that Prove Medical Text Messaging Is the Answer
Texting is a great way to communicate with patients anytime without being intrusive. It's easy. It's inexpensive. Best of all, it's what your patients want. But pudding is supposed to be full of proof, right? So we’ve put together this eBook with 16 stats that show without a doubt why you should start texting your patients, including:
• 75% of patients would prefer receiving appointment and payment reminders via text
• Text message response rates are 209% higher than those from phone calls
• The average practice could save up to 2 hours a day on phone calls by using text conversations
Start having REAL conversations with your patients. Download the eBook today!
The physicians at Advanced Vision Care, located in Los Angeles, Calif., had been using an outdated electronic health record (EHR) system that inadequately kept up with the changes in technology and government regulations. Having experienced frequent system outages and unacceptable customer service, productivity would only decline unless a change was made. Dr. Nicole Fram, managing partner and ophthalmologist at Advanced Vision Care, led the initiative to implement a new system and has never been happier.
"I am a better physician because of EMA in terms of improved communication with other doctors, due to the thorough and detailed documentation it generates. My notes are legible, intelligent, customizable and easy to read. EMA enables me to do all these things I’ve dreamt of in an EHR system and I'm no longer spending hours dictating each night."
— NICOLE FRAM, MD
To keep reading, download the case study below.
Let's face it. Without patients, you don't have a practice. Somehow you have to attract new patients and keep the ones you have without sacrificing patient care, medical billing, and a million other priorities!
You need an effective medical practice marketing strategy! Download this white paper now to discover 10 proven techniques, including how to:
- Boost physician's online reviews
- Improve physician's online reputation
- Offer more patient communication options
- Provide better patient education
- Engage patients through social media
When Dr. Don Abrams became the Chairman of Ophthalmology at the LifeBridge Health Krieger Eye Institute at Sinai Hospital in Baltimore, Md., he knew he wanted to implement an EMR system. He began looking at numerous systems that would support their various clinic locations, residency and fellowship programs and their multiple specialties only to be left with a disappointing solution.
Dr. Abrams explains, “We started using an EMR system in 2008 that we quickly found to be very cumbersome and outdated. The input of data was time consuming and the output was indecipherable. After a short six weeks of using the system, our productivity had plummeted so significantly that we couldn’t afford to continue using it. At that point we transitioned back to paper and I continued my search for the right EMR system.”
To keep reading, download the full case study below.
Understanding the Value of Your Current Patients to Your Future Success
Without a solid plan for retaining current patients, growth will not be possible or will be minimized at best. This white paper discusses how patient retention is a multidimensional issue that requires a multidimensional approach.
A few of the topics in this white paper include:
· How to communicate with patients
· What is an acceptable rate of attrition
· Using social media to retain patients
Download this white paper to learn more about best practices to retain patients.
Learn how to select, switch & adopt software solutions to thrive in the value based era
Eye Care Leaders knows that selecting the right technology is critical for making your lives easier. We've compiled best practices and strategies from leading experts in the eye care industry to ensure you get the most out of your software solutions. This guide will help you select the best EHR, PM and optical software for your practice to increase revenue and productivity.
Don't leave your patients adrift on the patient island
Healthcare practices are scrambling to juggle the ever-increasing number of regulations, demands, and expectations placed upon their shoulders. As a result, an unfortunate side effect has emerged—many patients report feeling rushed, ignored, or “like they are adrift on a patient island.” But there is a simple solution: compassion. Compassion based care has been found to have an astounding effect on both patients and practices.
How can you bring compassion back to the forefront of your practice?
Lutein has strong support for its role in ocular health and has recently been recognized for its cognition role during early life and childhood. This white paper looks at the evidence for lutein’s function in brain tissue, where it is the predominant carotenoid in both infants and adults. FloraGLO® Lutein is the only lutein brand approved for use in infant nutrition and the most clinically studied lutein brand in the world.
Response to supplementation with MacuHealth™ (a formulation consisting of meso-zeaxanthin [10 mg], lutein [10 mg] and zeaxanthin [2 mg]) was conducted by Moorfields Eye Hospital, London. The cohort of 49 subjects included those with non-advanced (n = 12) and advanced (n = 8) age-related macular degeneration, diabetic retinopathy with (n = 10) and without (n = 10) macular edema, central serous chorioretinopathy (n = 5) and no retinal disease (n = 4). By 6 months, statistically significant improvements in glare sensitivity (at low and medium spatial frequencies) were demonstrable, and reflected parallel statistically significant increases in macular pigment, prompting the investigators to conclude that supplementation with MacuHealth™ enhances visual performance and experience in healthy eyes and in eyes with a range of retinal diseases. These favorable observations by Moorfields Eye Hospital regarding the visual benefits of MacuHealth™ in diseased and in non-diseased eyes serve to replicate the findings of other investigators across the world.[2-4]
FloraGLO® Lutein sets the gold standard for the lutein market. Rooted in science, with an unparalleled reputation for efficacy, trust and safety, the FloraGLO® name is synonymous with excellence. “The Pioneers of Lutein Science and Discovery” offers the following:
- How researchers discovered the photoprotective properties of lutein and zeaxanthin;
- Why most adults aren’t getting enough in their diets; and
- How Kemin created a lutein supplement proven to increase macular pigment optical density (MPOD) in clinical trials.
Non-advanced age-related macular degeneration (AMD) does not profoundly affect vision, but is associated with gradual but relentless visual decline and, in many cases, progression to advanced and blinding AMD (atrophic and/or neovascular). Supplementation with antioxidants that include the macular carotenoids has been shown benefit patients with non-advanced AMD. A recent randomized, clinical trial has shown that a formulation containing all three macular carotenoids (in L:MZ:Z [mg] ratio of 10:10:2; MacuHealth with LMZ3 and MacuHealthPlus+ ) outperforms a MZ-deficient formulation in patients with non-advanced AMD, both in terms of visual improvements and in terms of observed increases in macular pigment.
Medical foods are an emerging category of product, formulated to address nutritional deficiencies relating to specific diseases or conditions. This whitepaper provides an insight into:
· The importance of targeted nutrition for eye health
· The medical food category: Guidelines, market size, regulations
· Macular pigment: Risk factor, biomarker, vision performance
· Lumega-Z: the first and only medical food developed to restore and maintain the macular pigment
Download the whitepaper to learn about this differentiated offering, and discover how to maximize the efficacy of your intervention, ensure patient compliance and satisfaction.